|
|
|
|
| LEADER |
03746nam a2200613 4500 |
| 001 |
ocm79369710 |
| 003 |
OCoLC |
| 005 |
20180501121909.0 |
| 006 |
m o d |
| 007 |
cr cnu---uuuuu |
| 008 |
041027s2004 ne af ob 001 0 eng d |
| 040 |
|
|
|a CtY-M
|b eng
|e pn
|c YUS
|d N$T
|d YDXCP
|d IDEBK
|d E7B
|d OCLCQ
|d MERUC
|d OPELS
|d OCLCQ
|d UIU
|d OCLCF
|d OCLCQ
|d EBLCP
|d NRU
|d OCLCQ
|d ESU
|e rda
|d MEU
|d OCLCO
|d GrThAP
|
| 019 |
|
|
|a 156853023
|a 476059033
|a 648303282
|
| 020 |
|
|
|a 9780080490403
|q (electronic bk.)
|
| 020 |
|
|
|a 0080490409
|q (electronic bk.)
|
| 020 |
|
|
|a 0120329522
|q (electronic bk.)
|
| 020 |
|
|
|a 9780120329526
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)79369710
|z (OCoLC)156853023
|z (OCoLC)476059033
|z (OCoLC)648303282
|
| 050 |
|
4 |
|a RC643
|b .T74 2004eb
|
| 060 |
|
4 |
|a WH 250 T784 2004
|
| 072 |
|
7 |
|a MED
|x 062000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99419
|2 22
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Treatment of Leukemia and Lymphoma /
|c edited by David A. Scheinberg, Joseph G. Jurcic.
|
| 264 |
|
1 |
|a Amsterdam ;
|a Boston :
|b Elsevier,
|c 2004.
|
| 300 |
|
|
|a 1 online resource (xvii, 393 pages, 4 unnumbered pages of plates) :
|b illustrations (some color).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in pharmacology ;
|v v. 51
|
| 546 |
|
|
|a Text in English.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Kinase Inhibitors in Leukemia -- Therapy of Acute Promyelocytic Leukemia -- Investigational Agents in Myeloid Disorders -- Methodologic Issues in Investigation of Targeted Therapies in Acute Myeloid Leukemia -- Purine Analogs in Leukemia -- Monoclonal Antibody Therapy in Lymphoid Leukemias -- Native Antibody and Antibody-Targeted Chemotherapy for Acute Myeloid Leukemia -- Radioimmunotherapy of Leukemia -- Immunotoxins and Toxin Constructs in the Treatment of Leukemia and Lymphoma -- Antibody Therapy of Lymphoma -- Vaccines in Leukemia -- Therapeutic Idiotype Vaccines for Non-Hodgkin's Lymphoma -- Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma -- Donor Lymphocyte Infusions -- Somatic Cell Engineering and the Immunotherapy of Leukemias and Lymphomas.
|
| 520 |
|
|
|a New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology. Detailed descriptions of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well as an understanding of their mechanisms of action and their integration into current therapy are provided.
|
| 650 |
|
0 |
|a Leukemia.
|
| 650 |
|
0 |
|a Lymphomas.
|
| 650 |
|
0 |
|a Blood
|x Diseases
|x Treatment.
|
| 650 |
|
2 |
|a Leukemia
|x drug therapy.
|0 (DNLM)D007938Q000188
|
| 650 |
|
2 |
|a Lymphoma
|x drug therapy.
|0 (DNLM)D008223Q000188
|
| 650 |
|
6 |
|a Sang
|x Maladies
|x Traitement.
|
| 650 |
|
6 |
|a Leucémie.
|
| 650 |
|
6 |
|a Lymphome.
|
| 650 |
|
7 |
|a MEDICAL
|x Oncology.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
| 650 |
|
7 |
|a Blood
|x Diseases
|x Treatment.
|2 fast
|0 (OCoLC)fst00834587
|
| 650 |
|
7 |
|a Leukemia.
|2 fast
|0 (OCoLC)fst00996894
|
| 650 |
|
7 |
|a Lymphomas.
|2 fast
|0 (OCoLC)fst01004321
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Scheinberg, David A.,
|e editor.
|
| 700 |
1 |
|
|a Jurcic, Joseph G.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Treatment of leukemia and lymphoma
|w (DLC) 2005270789
|w (OCoLC)56826601
|
| 830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v v. 51.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/10543589/51
|z Full Text via HEAL-Link
|
